Therapeutic Profile of IgA Nephropathy Regarding Pharyngeal Kidney Theory

Authors

  • Yao Ma Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi, China
  • Anbang Hao Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi, China
  • Fene Li Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi, China
  • Ping Fan Shaanxi Provincial Hospital of Chinese Medicine, Xi'an 710003, Shaanxi, China

DOI:

https://doi.org/10.53469/jcmp.2024.06(10).33

Keywords:

IgA nephropathy, Pharyngeal kidney theory, Traditional Chinese medicine, Etiology and pathogenesis

Abstract

IgA nephropathy (IgAN) is the most common glomerular disease, which is one of the main causes of chronic kidney disease. The course of this disease is prolonged, and the condition is often recurrent, and most of the disease changes after respiratory, gastrointestinal, and urinary infections, and respiratory infections are the most common of the three, which makes the treatment more difficult. In Chinese medicine, there is no direct name for this disease, but according to its symptoms, it can be categorized as "hematuria", "edema", "urolithiasis", "slow kidney wind" and other diseases. The disease is often caused by the recurrence of exogenous infections. For the recurrence of this disease due to exogenous infection, Chinese medicine treats IgA nephropathy from the pharynx according to the theory of "pharyngeal and renal correlation", which has achieved good clinical efficacy, and this point of view has received more and more attention nowadays. This article focuses on the treatment of IgA nephropathy from the pharyngeal-renal theory.

References

Li Zhuanglin, Gao Li. Progress of research on pathogenesis and clinical treatment of IgAN [J]. Chinese and foreign medicine research, 2018, 16(11):185-188.

Nie Lifang. Research on Chinese medicine disease name, symptomatic characteristics and treatment method of benefiting qi and nourishing kidney in IgA nephropathy [J]. Chinese Journal of Nephrology with Integrative Medicine and Western Medicine, 2015, 16(1):1-3.

Chen Xiangmei, Chen Yiping, Li Ping, et al. Multicenter epidemiological survey of Chinese medicine evidence in 1, 016 patients with IgA nephropathy and analysis of related factors [J]. Chinese Journal of Integrative Medicine, 2006, 26(3):197-201.

Liu YF, Chen BM, Wang JX, et al. A study on the distribution characteristics of 240 cases of IgA nephropathy in Chinese medicine with physical type and actual evidence [J]. Chinese Journal of Integrative Nephrology, 2017, 18(3):238-239.

WANG Xinrong, WAN Tingxin, ZHAO Zhuhua, et al. Study on microdiagnostic pathological indexes of damp-heat syndrome in IgA nephropathy in Chinese medicine [J]. China Journal of Traditional Chinese Medicine Information, 2015, 22(8):31-35.

Berger J, Hinglais N. Intercapillary deposits of IgA-IgG [J]. J Urol Nephrol(Paris), 1968, 74(9):694-695.

Suzuki H, Kiryluk K, Novak J, et al. The pathophysiology of IgA nephropathy [J]. J Am Soc Nephrol, 2011, 22(10):1795-1803.

Tortajada A, Gutierrez E, Pickering M C, et al. The role of complement in IgA nephropathy [J]. Mol Immunol, 2019, 114:123-132.

Amore A, Coppo R, Nedrud J G, et al. The role of nasal tolerance in a model of IgA nephropathy induced in mice by Sendai virus [J]. Clin Immunol, 2004, 113(1):101-108.

Coppo R. The intestine-renal connection in IgA nephropathy [J]. Nephrol Dial Transplant, 2015, 30(3): 360-366.

Smerud H K, Bárány P, Lindström K, et al. New treatment for IgA nephropathy: enteric budesonide targeted to the ileocecal region ameliorates proteinuria [J]. Nephrol Dial Transplant, 2011, 26(10):3237-3242.

Cheung C K, Rajasekaran A, Barratt J, et al. An update on the current state of management and clinical trials for IgA Nephropathy [J]. J Clin Med, 2021, 10(11):2493.

Knoppova B, Reily C, King R G, et al. Pathogenesis of IgA nephropathy: Current understanding and implications for development of disease-specific treatment [J]. J Clin Med, 2021, 10(19):4501.

LI Liu-Sheng, ZHAO Ming-Ming, ZHANG Yu. Zhang Yu's experience in diagnosis and treatment of IgA nephropathy based on the complex pathomechanism network of "deficiency-wind-stasis-toxicity" [J]. World Journal of Integrative Medicine, 2017, 12(4):450-455.

CHEN Weixin, LIU Baohou. Professor Liu Baohou's experience in the treatment of proteinuria [J]. Chinese Journal of Integrative Nephrology, 2021, 22(2):100-102.

Liu Chenke, Xu J, Liu Houying, et al. Experience of Wang Yulin famous old Chinese medicine practitioner in treating IgA nephropathy using Wang's nephritis soup [J]. Electronic Journal of Cardiovascular Diseases of Integrative Chinese and Western Medicine, 2019, 7(17): 52-53.

ZHU Xingyu, CHEN Ningning, FAN Yongsheng. Experience of Fan Yongsheng in treating IgA nephropathy [J]. Chinese Journal of Traditional Chinese Medicine, 2018, 33(10):4466-4468.

ZHANG Yi-Xin, WANG Yaoguang. A review of Prof. Huang Wenzheng's experience in treating IgA nephropathy by using the method of sparing the Shaoyang Sanjiao [J]. Tianjin Traditional Chinese Medicine, 2022, 39(1):4-7.

Chen Huixi, Li Jianmin, Xie Chen, et al. Prof. Li Jianmin's experience in treating IgA nephropathy [J]. China Medicine Herald, 2021, 18(24):136-138.

Ye Qing, Huang Botao, Yang Lina, et al. Appreciation of Zhu Bangxian's experience in treating IgA nephropathy by ascending Qing and descending turbidity, dispelling toxins and fixing kidney [J]. Shanghai Journal of Traditional Chinese Medicine, 2017, 51(1):5-7.

Xue Bingqing, Kong Wei. Experience of Kong Wei in treating hematuria in IgA nephropathy [J]. Shanxi Traditional Chinese Medicine, 2023, 39(8):4-6.

Xu Yan, Ding Cherry, Li Donglin, et al. Introduction of Ding Cherry's experience in treating IgA nephropathy based on kidney turbidity theory [J]. Chinese Journal of Basic Chinese Medicine, 2024, 30(2):316-318.

Ren Jixue. The collection of experience of Ren Jixue. Beijing: People's Health Publishing House, 2000:192.

Luo Denggui. Analyzing the law of identifying and treating Ig A nephropathy by famous Chinese medicine practitioners based on data mining [J]. Shandong Journal of Traditional Chinese Medicine, 2019, 38(11): 1037-1041, 1054.

Pan Lanlan, Song Chundong. Progress of traditional Chinese medicine treatment of Ig A nephropathy [J]. Chinese folk therapy, 2020, 28(7):101-103.

J. Zhao. Theoretical discussion on the treatment of Ig A nephropathy from the theory of ambulatory evil [J]. Chinese Journal of Traditional Chinese Medicine, 2019, 34(10):4709-4712.

Liu Shangjian. A preliminary study on the theory of "miniature obstruction in the abdomen by the kidney channel" [J]. China Journal of Basic Chinese Medicine, 2009, 15(9):649-650.

Chen Q, Wang W, Wang L. Research progress on the pathogenesis of Ig A nephropathy [J]. Journal of Practical Hospital Clinics, 2019, 16(2):242-245.

Wang Zhilei, Zheng Xue, Zhang Shoulin. Research progress of Ig A nephropathy based on mucosal-myeloid axis [J]. Journal of Changchun University of Traditional Chinese Medicine, 2021, 37 (3):678-683.

Wyatt RJ, Julian BA. Ig A nephropathy [J]. N Engl J Med, 2013, 368(25):2402-2414.

Coppo R. The gut-kidney axis in Ig A nephropathy: role of microbiota and diet on genetic predisposition [J]. Pediatric Nephrology (Berlin, Germany), 2018, 33(1): 53-61.

Li Chunlei. Experimental study on the correlation between lung main guard qi and skin mucous membrane immunity [J]. Proceedings of the Eighth Academic Conference of Experimental Pharmacology of Chinese Medicines Branch of the Chinese Society of Traditional Chinese Medicine, 2009.127.

Rodrigues JC, Haas M, Reich HN. IgA Nephropathy. Clin J Am Soc Nephrol. 2017;12(4):677-686.

Seikrit C, Pabst O. The immune landscape of IgA induction in the gut. Semin Immunopathol. 2021; 43(5): 627-637.

Gesualdo L, Di Leo V, Coppo R. The mucosal immune system and IgA nephropathy. Semin Immunopathol. 2021 Oct;43(5):657-668.

Chen X, Yan Z, Pan Q, Zhang C, Chen Y, Liang X, Li S, Wu G. Bibliometric analysis of mucosal immunity in IgA nephropathy from 1990 to 2022. Immun Inflamm. Dis. 2024 Jan;12(1):e1156.

CHEN Qi, ZHOU Jingwei, CHEN Zhenjie, et al. Exploration of mucosal immune mechanisms in IgA nephropathy based on the theory of volatile evil and warm disease [J]. Journal of Chinese Medicine, 2022, 37(12): 2525-2529.

Floege J, Feehally J. The mucosa-kidney axis in IgA nephropathy. Nat Rev Nephrol. 2016;12(3):147-156.

Kiryluk K, Li Y, Scolari F, et al. Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens. Nat Genet. 2014;46(11):1187-1196.

Harabuchi Y, Takahara M. Recent advances in the immunological understanding of association between tonsil and immunoglobulin A nephropathy as a tonsil-induced autoimmune/inflammatory syndrome. Immun Inflamm Dis. 2019;7(2):86-93.

Fellström BC, Barratt J, Cook H, et al. Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomized, placebo-controlled phase 2b trial. lancet. 2017;389(10084):2117-2127.

Wang LY, Liu N, Zhang PQ. Zhang Peiqing's experience in treating Ig A nephropathy with tonsillar anomalies. Shanghai Journal of Traditional Chinese Medicine, 2008(6):10-11.

Wang G. Modern Chinese medicine treatment of Ig A nephropathy Nanjing: Jiangsu Science and Technology Press, 2006:71-75.

Li Xue, Chen J, Ma F, et al. Exploration of the theory and practice of Ig A nephropathy treated from pharyngeal theory by Prof. Jim Yongli. World Chinese Medicine, 2019, 14(4):1002-1005+1010.

Chen Xiangmei, Deng Yueyi, Xie Yansheng, A practical guideline for western medical diagnosis and traditional Chinese medicine identification and staging of Ig A nephropathy. Chinese Journal of Integrative Medicine, 2013, 33(5):583-585.

Zhou Yingchen. Professor Zou Yanqin's experience in the treatment of Ig A nephropathy. Journal of Changchun University of Traditional Chinese Medicine, 2012, 28(5):799-800.

Ba Yuanming, Lin Xiaoyuan. Shao Chaodi's experience in treating Ig A nephropathy. Shizhen Guomao Guomao, 2015, 26(3):707-708.

Nie Li-Fang, Yu R-Huan, Yu D-Jun. Analysis of Chinese medicine diagnostic studies of Ig A nephropathy in China in the past 15 years. Shanghai Journal of Traditional Chinese Medicine, 2004(2): 59-61.

Zhang Y, Yu RH, Sun HY. Experience of Nie Lifang's method of benefiting qi and nourishing kidney in treating Ig A nephropathy. Journal of Traditional Chinese Medicine, 2014, 55(24):2084-2086.

Xingyu Zhu, Ningning Chen, Yongsheng Fan. Experience of Fan YS in treating Ig A nephropathy. Chinese Journal of Traditional Chinese Medicine, 2018, 33(10):4466-4468.

Li WM, Huang D, Shen PC, et al. Benefiting qi and consolidating and regulating immunity formula for the treatment of IgA nephropathy with heat-knotting pharyngeal syndrome in qi and yin deficiency type. Chinese Journal of Experimental Formulary, 2016, 22(1):166-170.

Wang XH, Liang Y, Yu RH, et al. Clinical study on the treatment of IgA nephropathy with pharyngeal inflammation by Yiqi nourishing yin and pharyngeal benefit formula combined with pharyngeal pecking treatment. Chinese Journal of Integrative Medicine, 2019, 39(1):52-56.

Wang JM. Clinical study on the treatment of Ig A nephropathy from pharyngeal theory in Chinese medicine. Chinese Journal of Integrative Nephrology, 2018, 19(1):74-75.

Li S-P. Exploring the effect of Chinese medicine "pharyngeal treatment" in the treatment of Ig A nephropathy. Shenzhen Journal of Integrative Medicine, 2015, 25(15):60-62.

Du An-Min. Clinical study on the treatment of Ig A nephropathy by pharyngeal therapy in traditional Chinese medicine. Asia-Pacific Traditional Medicine, 2014, 10(8):69-70.

He Y. Investigation of mucosal involvement in 108 patients with Ig A nephropathy. Chinese Journal of Kidney 1151 Disease with Integrative Medicine, 2013, 14(12):1095-1096.

Wu G, Peng Y M, Liu H, et al. Expression of CD19(+) CD5(+) B cells and Ig A1 positive cells in tonsillar tissues of Ig A nephropathy patients. 2011, 33(2): 159-163.

Xie Y, Chen X, Nishi S, et al. Relationship between tonsils and Ig Anephropathy as well as indications of tonsillectomy. Kidney Int, 2004, 65(4):1135 Kidney Int, 2004, 65(4):1135-1144.

Yang D, He L, Peng X, et a1. The efficacy of tonsillectomy on clinical remission and relapse in patients with Ig A nephropathy: a randomized controlled trial. Ren Fail, 2016, 38(2):242-8.

Liu LL, Wang LN, Jiang Y, et al. Tonsillectomy for Ig A nephropathy: a meta-analysis. Am J Kidney Dis, 2015, 65(1):80-87.

Duan J, Liu D, Duan G, et a1. Longterm efficacy of tonsillectomy as a treatment in patients with Ig A nephropathy: a meta-analysis. Int Urol Nephrol. 2017, 49(1): 103-112.

Adachi M, Sato M, Miyazaki M, et al. Steroid pulse therapy transiently destroys the discriminative histological structure of tonsils in Ig Anephropathy: Tonsillectomy should be performed before or just after steroid pulse therapy. Auris Nasus Larynx. 2018 Dec; 45(6):1206-1213.

Feehally J, Coppo R, Troyanov S, et al. Tonsillectomy in a European Cohort of 1, 147 Patients with Ig A Nephropathy. Nephron, 2016, 132(1):15-24.

Downloads

Published

2024-10-29

How to Cite

Ma, Y., Hao, A., Li, F., & Fan, P. (2024). Therapeutic Profile of IgA Nephropathy Regarding Pharyngeal Kidney Theory. Journal of Contemporary Medical Practice, 6(10), 159–166. https://doi.org/10.53469/jcmp.2024.06(10).33